by Shannon Hayes | Feb 26, 2025 | Industry News and Updates, Top Stories
Last December, the FDA announced “shortage” of tirzepatide, last month about Eli Lilly suing Medspa, and just last week, we saw the FDA announce that compounding pharmacies must stop the production and sale of semaglutide. style="display:block"...
by Shannon Hayes | Feb 25, 2025 | Industry News and Updates, Top Stories
As someone who has been involved in medspa industry from a unique angle for years now, I was thrilled when I heard that Kyle Scheele was chosed as the Keynote at the 2025 conference in Vegas in April. Alex Thiersch and Cathy Christensen spoke with Kyle on...
by Shannon Hayes | Feb 22, 2025 | AI, AI and Technology, Top Stories
AI is transforming industries, from content creation to automation. Based on the latest TechRadar survey, these are the top 10 AI tools that people are using the most in 2025. If you’re wondering which AI tool is right for you, this guide will help you make an...
by Shannon Hayes | Feb 21, 2025 | Industry News and Updates, Top Stories
In a move that could shake up the medical spa industry, the FDA has officially resolved the shortages of Ozempic and Wegovy, signaling a potential crackdown on compounded semaglutide. This decision directly impacts medspas offering weight loss services, as many have...
by Shannon Hayes | Feb 21, 2025 | Marketing and Growth, Top Stories
Six hundred sixty-two million dollars. That’s how much Americans spent on neurotoxins like Botox in 2023 alone. But behind every dollar spent lies a critical moment of decision-making that happens faster than you might realize. Trust is currency in the medspa...
